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Activation of ERK in renal fibrosis after unilateral ureteral ob-
struction: Modulation by anti-oxidants.
Background. A recent in vitro model of oxidative stress-
induced renal fibrosis demonstrated that activated or phospho-
rylated extracellular signal-regulated protein kinase (pERK)
played a role in apoptosis of renal fibroblasts, but not tubu-
lar epithelium where it promoted cell growth and survival. The
present study utilized an in vivo model of renal fibrosis after uni-
lateral ureteral obstruction (UUO) to examine the relationship
between pERK, apoptosis, proliferation, and differentiation in
renal fibroblast and tubular epithelial cells, in comparison with
the in vitro results.
Methods. UUO was induced in rats for 0 (controls, un-
treated), 6, and 24 hours, 2, 4, and 7 days (N = 4), and tissue
analyzed for fibrotic characteristics using microscopy and spe-
cial stains, Western immunoblots and reverse transcription-
polymerase chain reaction (RT-PCR). Controls and UUO
animals were also treated with vitamin E, N-acetylcysteine
(NAC), or fluvastatin to assess any antioxidant effect on at-
tenuation of fibrosis and pERK expression.
Results. Azan stain and a-smooth muscle actin (a-SMA),
collagen III, and fibronectin expression confirmed devel-
opment of UUO-induced fibrosis. Oxidative stress markers
heme oxygenase-1 (HO-1) and 8-hydroxy-2′-deoxyguanosine
(8-OHdG) confirmed oxidative stress at all UUO time points.
Tubular epithelial and interstitial mitosis and apoptosis were
significantly increased over controls at 2 to 7 days after UUO
(P < 0.01). The pERK/ERK ratio increased significantly at 1 to
7 days of UUO in comparison with controls (three- to fivefold,
P < 0.05). There was a significant spatiotemporal correlation be-
tween pERK and tubular epithelial proliferation (P < 0.001).
pERK occasionally colocalized with apoptotic cells (dual la-
beling) in the interstitium but not in the tubular epithelium.
Fluvastatin was the only treatment that attenuated fibrosis (de-
creased a-SMA, fibronectin, tubular epithelial apoptosis) and
it also significantly decreased expression of 8-OHdG at 2 and
7 days (P < 0.05). It was associated with decreased pERK at
7 days, compared with UUO alone (P < 0.05).
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Conclusion. Promotion of tubular epithelial proliferation
and survival, and interstitial cell apoptosis, may minimize re-
nal fibrosis after UUO. In the present study, both were linked
spatially and temporally with increased pERK expression. Flu-
vastatin treatment attenuated UUO-induced fibrosis via an an-
tioxidant and pERK-related mechanism.
Ureteral obstruction leads to tubulointerstitial fibro-
sis, a process that involves increasing populations of in-
terstitial inflammatory cells, such as myofibroblasts [1],
lymphocytes and macrophages [2], activation and trans-
differentiation of intrinsic renal cells [3], and increas-
ing tubular atrophy and interstitial extracellular matrix
(ECM) accumulation [4, 5]. Tubular atrophy is associ-
ated with increased apoptosis that is not balanced by ele-
vated levels of tubular cell proliferation seen in the early
or acute stages of renal fibrosis [6–8]. Although consid-
erable advances have been made in understanding the
pathogenesis of renal fibrosis due to unilateral ureteral
obstruction (UUO), there are few published data, either
experimental or clinical, that describe the early transduc-
tion events of fibrogenic signals. These pathways need
further definition.
Although the pathogenesis of tubulointerstitial fibrosis
is undoubtedly multifactorial, one of its early modulators
is oxidative stress [9–12]. Localized oxidative stress may
be cytotoxic to renal tubular epithelial cells [13, 14], re-
sulting in increased apoptosis [15]. There is also some in-
dication that oxidative stress plays a role in transforming
growth factor-b1 (TGF-b1) expression and in production
of ECM in tubulointerstitial fibrosis [16]. Attenuation of
renal fibrosis may occur via a fluvastatin-induced reduc-
tion of oxidative stress [12]. Oxidative stress has been
linked to tubulointerstitial fibrosis via the activation of
intracellular second messenger signaling pathways, for
example, after diabetic nephropathy (reviewed in [17]).
More specifically, members of the mitogen-activated pro-
tein kinase (MAPK) family of signaling molecules, one of
the best-characterized of the signal transduction families,
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are known to be activated in renal cells by oxidative stress
[18, 19].
The MAPK family utilizes three parallel signaling path-
ways: extracellular signal-regulated kinase (ERK); stress-
activated protein kinase/c-Jun amino terminal kinase
(SAPK/JNK); and p38 MAPK [20]. The ERK pathway is
usually stimulated by serum and growth factors and ac-
tivation of its cascade stimulates mitosis, cell differentia-
tion, and in some cells, hypertrophy [21]. ERK activation
has been identified in proliferative glomerulonephritis in
rats [22] and it may play a role in oxidant-dependent path-
ways that lead to renal injury [23]. Additionally, there are
emerging data indicating that hydrogen peroxide (H2O2)
can activate ERK in association with cell death [19, 24–
26]. This association may be specific to different cell types
making up the renal population. For example, in an in
vitro model of oxidative stress-induced renal fibrosis, ac-
tivated or phosphorylated ERK (pERK) was part of the
apoptotic pathway of renal fibroblasts, in comparison
to the renal tubular epithelium where it supported cell
survival [19].
The present study utilized an in vivo model of re-
nal fibrosis after UUO in rats to examine the relation-
ship between pERK, apoptosis, proliferation, and differ-
entiation in renal fibroblast and tubular epithelial cells.
The aim of this study was to characterize the changes in
pERK expression and localization over a 7-day period af-
ter UUO in comparison with oxidative stress [measured
by oxidative stress markers heme oxygenase-1 (HO-1)
or 8-hydroxy-2′-deoxyguanosine (8-OHdG) [27]], and
known characteristics of tubulointerstitial fibrosis [a-
smooth muscle actin (a-SMA), collagen, fibronectin],
cellular proliferation [proliferating cell nuclear antigen
(PCNA)], and apoptosis [morphology and in situ end
labeling (ISEL)]. Colocalization between pERK and
PCNA, a-SMA or ISEL was examined. The results were
compared with those found using an in vitro oxidative
stress model of renal fibrosis [19]. The effects of cotreat-
ment of UUO-associated fibrosis with the putative an-
tioxidants vitamin E, N-acetylcysteine (NAC), or fluvas-
tatin were also investigated.
METHODS
Animals and surgery
All experiments were performed with ethics approval
from the University of Queensland Animal Experimenta-
tion Ethics Committee (Number Path/RBH/732/03/RD).
Male Sprague-Dawley rats weighing 180 to 220g were al-
lowed free access to water and standard rat food and
were housed in an air-conditioned room with 12/12 hours
light/dark cycle. Animals were anesthetized with pento-
barbital sodium (60 mg/kg, intraperitoneally). Normal
body temperature was maintained throughout surgery.
Animals were divided into sets of controls (no opera-
tion) and UUO animals, which were or were not treated
with the antioxidants vitamin E (40 mg/kg/day), NAC
(50 mg/kg/day) (both Sigma-Aldrich, Sydney, Australia),
or fluvastatin (40 mg/kg/day) (Novartis Pharmaceuticals
Australia Pty. Ltd., North Ryde, Australia) (N = 4 per
control or treatment group). UUO or control sets were
studied for 6 and 24 hours and 2, 4, or 7 days. Sham surgery
was not used for controls based on previous work [6]
indicating no difference between untreated and sham-
operated controls. For UUO groups, the left kidney was
exposed with a midabdominal incision and a double liga-
ture placed on the left ureter approximately 1 cm from the
renal hilum, before closing the abdominal incision with
4-0 silk and Michel clips. The antioxidants were either
either injected intraperitoneally (vitamin E and NAC)
or were administered by oral gavage (fluvastatin in 1%
methyl cellulose). Control groups for antioxidant treat-
ments received an injection or gavage vehicle. For tis-
sue collection, animals were heavily anesthetized, aortic
blood was collected for function studies, and then both
kidneys removed prior to the animal’s death.
Preparation of tissue
Each kidney was quickly sliced transversely (2 to 3 mm
slices) to the length of the kidney. The slices closest to the
equatorial plane were either fixed in 10% buffered for-
malin for histology and immunohistochemistry, or snap
frozen in liquid nitrogen and stored at −80◦C in 22-
oxacalcitriol (OCT) for frozen sections, if required. The
adjacent slices were frozen at −80◦C in two lots for ei-
ther protein or RNA extraction and analysis. Note: Sev-
eral human UUO samples (N = 4) were available from
the Department of Nephrology, China Medical Univer-
sity, Shenyang, People’s Republic of China (Professor C.
Kong) and they were sectioned and used for comparison
with rat samples, using hematoxylin and eosin staining
and immunohistochemistry.
Histology
Formalin-fixed tissue was embedded in paraffin using
routine methods, 4 lm sections were cut onto Superfrost
Plus histology slides, and stained with hematoxylin and
eosin (routine histology), Azan stain for collagen and fi-
brosis, ISEL for apoptosis, PCNA for cell proliferation,
periodic acid-Schiff (PAS) reagent for identification of
proteinaceous casts, a-SMA for identification of myofi-
broblasts, and pERK for localization of the activated
ERK protein.
Immunohistochemistry or immunofluorescence
Subserial sections were cut, numbered, deparaffinized,
and rehydrated, before staining with the peroxidase-
antiperoxidase method. Nonspecific binding of peroxi-
dase or antibodies was blocked with 0.3% H2O2 in 4%
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skim milk powder (blotto) followed by incubation in di-
luted normal rabbit or goat serum. Primary antibodies
were a-SMA (mouse monoclonal) (Sigma-Aldrich Pty
Ltd, Sydney, Australia) (1:100 dilution), PCNA (mouse
monoclonal) (Dako, Glostrup, Denmark) (1:50 dilution),
pERK (rabbit polyclonal) (New England Biolabs, Bev-
erly, MA, USA) (1:400 dilution), and 8-OHdG (goat poly-
clonal) (Chemicon, Boronia, Australia) (1:2000 dilution)
used as a marker of oxidative stress in situ [27]. The ap-
propriate secondary antibody was applied at a dilution
of 1:200 to 1:400 in Tris buffer. Secondary antibodies
were either conjugated to Alexa-Fluor or Texas Red flu-
orophores for immunofluorescence (Molecular Probes,
Eugene, OR, USA) or the peroxidase-antiperoxidase re-
action plus the chromogen diaminobenzidine tetrahy-
drochloride (DAB) for immunohistochemistry. Negative
controls were prepared without primary antibody, or with
nonspecific serum. Positive tissue control sections from
unrelated studies were included. Sections were lightly
counterstained with hematoxylin and then dehydrated in
ethanols, cleared in xylene and mounted in Depex.
Double staining using immunofluorescence. In some
instances, double staining for proteins was used in
paraffin sections. Rehydrated sections were washed in
Tris-buffered saline (TBS)/0.1% Tween-20 (TBST) and
nonspecific sites were blocked with 3% bovine serum al-
bumin (BSA) in TBST for 1 hour at room temperature.
Sections were incubated with primary antibody against
pERK (1:400) in 3% BSA in TBST overnight at 4◦C.
Sections had 3 × 10 minute washes in TBST, then in-
cubation with a second primary antibody (from a differ-
ent species to the first primary antibody) against a-SMA
(1:50) in 1% BSA in TBST for 1 hour at room tempera-
ture in the dark. Sections were washed 3 × 30 minutes in
TBST, then incubated with a fluorescent secondary anti-
body mixture containing an Alexa-Fluor labeled goat a-
rabbit IgG and Texas Red-X–labeled goat a-mouse IgG
(Molecular Probes), each at a dilution of 1:200 in 1% BSA
in TBST for 1 hour at room temperature. Sections were
washed 3 × 30 minutes in TBS, then mounted with glass
coverslips using either Dako fluorescent antifade mount-
ing medium (Dako, Botany, New South Wales, Australia)
or Vectashield mounting medium for fluorescence with 4′-
6-diamadino-2-phenylindole (DAPI) (Vector Laborato-
ries, Burlingame, CA, USA) and allowed to set overnight
in the dark prior to fluorescence microscopy.
ISEL
Following published methods [28, 29], sections were
dewaxed, rehydrated, digested in 0.5% pepsin in 0.1
mol/L HCl for 15 minutes at 37◦C, then washed in
TBS. Cells with DNA strand breaks were detected us-
ing a reaction mix containing Klenow DNA polymerase
I and biotin-labeled deoxyuridine triphosphate (dUTP),
as well as other products necessary for the ISEL re-
action mix [29] (all products from Roche Diagnostics,
Castle Hill, Australia). Endogenous peroxidase activity
was blocked with 0.1% H2O2, and biotin-labeled nu-
clei visualized with horseradish peroxidase-conjugated
avidin (Dako) developed in DAB and counterstained
with hematoxylin. Negative controls had no Klenow poly-
merase, and positive controls were rat renal sections from
other experiments in which high levels of ISEL were
known to correlate with high levels of apoptosis assessed
morphologically. Alternatively, sections were stained us-
ing a similar end-labeling procedure using a commercially
available ApopTag Peroxidase In Situ Apoptosis De-
tection Kit according to the manufacturer’s protocol for
paraffin-embedded sections (Serologicals Corporation,
Chemicon). For dual labeling of apoptosis and pERK, the
ApopTag Kit was used first and methods completed to
DAB and a buffer wash, then routine pERK immunoflu-
orescence methods were applied and sections mounted
in antifade aqueous mounting medium.
Assessment of morphologic and immunohistochemistry
characteristics
As far as possible, assessments were carried out with no
knowledge of treatment, although the dilatation of the re-
nal pelvis with progressive UUO made some time points
obvious during microscopy. Light microscopic evaluation
was performed using a magnification of ×400 in 10 to 20
randomly selected fields and recorded, where appropri-
ate, as positive cells per mm2 of tissue (the field of view
at ×400 was 0.0625 mm2 for the microscope used for all
analyses). Results are presented as mean ± standard er-
ror of the mean (SEM). Control sections had no patho-
logic changes.
Azan-stained sections. Blue collagen staining of the
tubulointerstitium in Azan-stained sections was scored
(Azan score) as the% range of tubules showing thick-
ening of the basement membrane and expansion of the
surrounding interstitium (for example, 0% collagen stain,
0; 1% to 25%, 1; 26% to 50%, 2; and >50%, 3). Stain-
ing of normal basement membrane and vessel walls was
ignored.
Apoptosis. Previously defined morphologic criteria
were used to count apoptotic cells in the tubular epithe-
lium or interstitium of hematoxylin and eosin–stained
sections [30]. These characteristics included cellular
rounding and shrinkage, eosinophilic cytoplasm, nuclear
chromatin compaction, especially along the nuclear en-
velope in a crescentic manner, membrane-bound cellular
blebbing, and formation of apoptotic bodies which may
appear in the tubular lumina or be phagocytosed by in-
trinsic renal cells or invading macrophages.
ISEL. ISEL nuclear positivity was counted in epithe-
lial and interstitial cells. ISEL is an indication of DNA
fragmentation and equates well with apoptosis when mor-
phologic comparisons are made. For example, a compari-
son between apoptosis assessed using morphology versus
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ISEL produced a Pearson’s R = 0.6833 with significance
at P < 0.0001 in a two-tailed test.
Cell proliferation. PCNA-positive nuclei were
counted. Mitotic nuclei were also assessed in comparison
with PCNA labeling.
a-SMA and pERK immunohistochemistry. Im-
munolocalization in the tubulointerstitium was recorded.
a-SMA positivity of vessel walls was ignored. Where dou-
ble labeling of pERK and PCNA (pERK/PCNA) was
used, counts were calculated as a % of all labeled cells
for pERK or PCNA alone or dual-labeled cells and pre-
sented as a graph of pERK/PCNA against pERK labeling
for each time point.
8-OHdG immunohistochemistry. Localization and ex-
pression intensity of 8-OHdG in the tubulointerstitium
were recorded at ×400 magnification in batch-stained
sections using a range where 0 was no labeling, 1 was
<50% area labeling of low intensity; 2 was <50% area
labeling with high intensity; 3 was >50% area labeling
with low intensity; and 4 was >50% area labeling of high
intensity. Means ± SEM were calculated for each exper-
imental group and recorded as an index of expression.
Western blot for protein analysis
Tissue was disrupted in ice-cold cell lysis buffer
(50 mmol/L Tris-Cl, pH 7.5, 150 mmol/L NaCl, 1%
Nonidet P-40, 0.1% sodium dodecyl sulfate (SDS),
25 mmol/L sodium fluoride, and 0.5 mol/L ethylene-
diaminetetraacetic acid) containing protease and phos-
phatase inhibitors (100 lg/mL phenylmethylsulfonyl
chloride, 20 lg/mL leupeptin, 20 lg/mL aprotinin, and
1 mmol/L sodium orthovanadate) (all Sigma-Aldrich
products) using a tissue homogenizer. Cell debris was
removed by centrifugation at 16,000g for 15 minutes at
4◦C. Protein concentration was determined in each tissue
extract by a Bradford protein assay (Bio-Rad Pty Ltd.,
Sydney, New South Wales, Australia) and spectroscopy
at 595 nm. Between 20 and 40 lg of total protein were
electrophoresed on a 8% to 12% SDS-polyacrylamide
gel using a Bio-Rad mini-protean unit, transferred to a
polyvinylidene difluoride (PVDF) membrane, and blot-
ted routinely with ERK (1:1000), pERK (1:1000), HO-1
(Stressgen, Victoria, British Columbia, Canada) (1:2000),
a-SMA (1:2000), collagen III (Research Diagnostics Inc.,
Flanders, NJ, USA) (1:1000), and fibronectin (BD Bio-
sciences Pharmingen, North Ryde, New South Wales,
Australia) (1:1000) primary antibodies, then appropriate
horseradish peroxidase-conjugated secondary antibod-
ies diluted (1:2000) in 5% blotto. Immunoblotting with
anti-HO-1 antibody was used as an indirect measure-
ment of oxidative stress, along with reverse transcription-
polymerase chain reaction (RT-PCR) (details below).
HO-1 is an inducible form of the HO enzyme [31], which
has been shown to be a reliable and early marker of ox-
idative stress in renal disease [32–34]. Protein bands were
visualized using enhanced chemiluminescence (ECL). X-
ray film was scanned using a Hewlett Packard ScanJet
3200C at 300dpi and Scion Image (b4.0.2) software was
used to quantify the density of the bands in arbitrary den-
sitometry units. Membranes were routinely stained with
Coomassie Blue (Sigma-Aldrich), or actin immunoblots
were used, to verify equal protein loading of lanes. Posi-
tive cell extracts from antibody suppliers were routinely
used as positive controls for immunoblots.
RT-PCR of HO-1
Total RNA was extracted using Qiagen’s RNeasy Mini
Prep Kit (Qiagen, Sydney, New South Wales, Australia)
according to the manufacturer’s protocols for animal tis-
sue. Total RNA was eluted with RNase-free H2O in a
final volume of 50 to 60 lL. Extracted RNA was tested
for purity and integrity by spectrophotometry at 260 nm
and 280 nm and electrophoresed on a 1.5% formalde-
hyde agarose gel prior to RT-PCR. RNA was routinely
treated with DNA-freeTM (Ambion, Austin, TX, USA)
to remove contaminating genomic DNA. One to three
micrograms were reverse transcribed in a total reaction
volume of 20 lL using the SuperscriptTM First Strand Syn-
thesis System for RT-PCR (Invitrogen, Life Technologies,
Sydney, New South Wales, Australia). Controls lacking
SuperscriptTM enzyme (no RT) or template RNA (−R)
and control RNA (provided by the manufacturer) were
run in conjunction with all sample reactions to monitor
the efficiency and integrity of the RT reaction. Primers
for rat HO-1 were designed in Primer 3.0 software
(MIT) from rat HO-1 cDNA sequence (NCBI Genbank
database accession number NM 012580) [35]. The HO-
1 primer pair used for PCR was forward primer (5′-
CAGTCTATGCCCCGCTCTAC-3′) and reverse primer
(5′-ACCAGCAGCTCAGGATGAGT-3′). b-actin was
utilized as a loading control using the following forward
primer (5′-ACTATCGGCAATGAGCGGTTC-3′) and
reverse primer (5′-ATGCCACAGGATTCCATACCC-
3′).
Renal functional parameters
Plasma sodium, potassium, creatinine, blood urea ni-
trogen (BUN), and lactate dehydrogenase (LDH) were
measured using a Hitachi Modular Blood Analyzer
(Hitachi Australia, Milton, Australia) at the Queensland
Health Pathology and Scientific Services Unit, Royal
Brisbane Hospital, Brisbane, Australia.
Statistical analyses
Data were analyzed using standard statistical methods,
linear regression, Student t test, one-way analysis of vari-
ance (ANOVA) and Dunnet’s multiple comparison or
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Fig. 1. Azan staining for collagen. Histo-
chemistry for 4 (A) and 7 (B) days’ uni-
lateral ureteral obstruction (UUO) animals
shows an increasing amount of tubulointer-
stitial collagen (blue stain), with a large area
of fibrosis marked with arrowheads (B). The
Azan scores (mean ± SEM of the degree of
collagen) are presented graphically (C) and
demonstrate a significant increase in Azan
scores at 2 to 7 days UUO. ∗P < 0.05.
∗
∗
75
50
25
0
N
um
be
r o
f a
SM
A 
(+)
ce
lls
 in
 in
te
rs
tit
ia
l s
pa
ce
6hr 24hr 2d 4d 7d
UUO, duration
*
*
αSMA IHC
D
Fig. 2. a-Smooth muscle actin (a-SMA)
immunohistochemistry (IHC). (A) Control
staining is demonstrated, where only vessels
stained positive (arrow). (B and C) a-SMA
positivity in the interstitium of 2 and 7 days’
unilateral ureteral obstruction (UUO) ani-
mals (white asterisks) (arrowheads and an ar-
row indicate mitotic and apoptotic cells, re-
spectively). (D) Mean ± SEM of a-SMA–
positive cells per mm2 of tissue in UUO an-
imals. There was a significant increase in in-
terstitial cell positivity at 4 and 7 days’ UUO.
∗P < 0.05.
Bonferroni’s post test using Graphpad Prism (version 3.0)
and Stata (version 8.0) statistical software. Most data are
presented in graphic form as the mean ± SEM. Signifi-
cance was assessed at P < 0.05.
RESULTS
Renal function
There were no significant differences found in any of
the selected functional parameters of UUO animals in
comparison with controls in the 7 days studied. Compen-
satory functional changes in the right non-UUO kidney
were thought to maintain normal bilateral renal function
as measured by plasma chemistry [36].
Development of fibrosis in UUO groups
Fibrosis was assessed by Azan histochemical staining
for collagen, a-SMA immunostaining for activated fi-
broblasts, and whole tissue protein expression by West-
ern immunoblot analysis for a-SMA, collagen III, and
fibronectin. Figure 1A and B demonstrate Azan staining
in 4 and 7 day UUO animals and Figure 1C represents the
mean ± SEM of the Azan score. There was a significant
increase in Azan score at 2, 4, and 7 days UUO in compar-
ison with 6 and 24 hours’ UUO animals (P < 0.05). Im-
munohistochemistry of a-SMA is presented in Figures 2A
to C. Figure 2A shows labeling of a-SMA only in vessels
of control kidneys. a-SMA–labeled cells increased in the
interstitium over time in UUO animals (Fig. 2B and C) (2
and 7 days, respectively). The mean number of a-SMA–
positive interstitial cells increased significantly in 4 and
7 days’ UUO kidneys in comparison with controls (P <
0.05) (Fig. 2D). There were no a-SMA–positive cells in
the tubular epithelium. Figure 3 demonstrates represen-
tative Western blots for whole kidney protein expression
of a-SMA, collagen III, and fibronectin for control or
UUO animals. All fibrotic markers were significantly in-
creased in UUO animals at 4 or 7 days (P < 0.05) in
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Fig. 3. Markers of fibrosis. Western blots for a-smooth muscle actin
(a-SMA), collagen III, and fibronectin (selected fibrotic markers) and
the associated densitometry (mean ± SEM) are presented for control or
unilateral ureteral obstruction (UUO) animals. There was a significant
increase in expression of all fibrotic markers at 4 and 7 days’ UUO. ∗P <
0.05 in comparison with controls.
comparison with controls, confirming the development
of significant fibrosis by these times.
UUO induction of oxidative stress
The involvement of oxidative stress in the develop-
ment of UUO-induced fibrosis was assessed by HO-1
induction (Fig. 4). RT-PCR indicated a significant peak
in HO-1 transcription (normalized to b-actin) at 6 hours
UUO (P < 0.01). Western blot analysis and densitometry
demonstrated a significant and increasing level of HO-1
protein in total kidney from 6 hours to 7 days UUO (P <
0.01). The 8-OHdG immunohistochemistry index verified
the induction of oxidative stress in UUO kidneys (data
presented in following section on modulation of fibrosis).
Tubulointerstitial mitosis and apoptosis
Mitosis and apoptosis in the tubular epithelium and in
the interstitium were compared and results are presented
as histology and quantification. Labeling of PCNA-
positive nuclei in 2 and 7 days’ UUO kidneys was consis-
tently and significantly higher than controls (Fig. 5A to
C). Using both morphology (Fig. 5D) and PCNA (Fig. 5E)
for quantification, mitosis peaked in the tubular epithe-
lium at 2 days’ UUO and remained significantly elevated
at 4 and 7 days (P < 0.01 to P <0.05). In the intersti-
tium, a moderate but significant increase in interstitial
cell proliferation occurred from 2 to 7 days’ UUO, indi-
cating an increase in interstitial inflammatory cell popu-
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Fig. 4. Heme-oxygenase (HO-1) expression. Reverse transcription-
polymerase chain reaction (RT-PCR) indicates a significant peak in
HO-1 transcription (P < 0.01) at 6 hours’ unilateral ureteral obstruc-
tion (UUO) after b-actin normalization and Western immunoblot and
densitometry demonstrate a significant and increasing level of HO-1
protein in total kidney from 6 hours to 7 days’ UUO. ∗P < 0.01.
lations. Figure 6A and B demonstrates apoptosis in the
tubular epithelium and interstitium in hematoxylin and
eosin sections, and Figure 6C demonstrates ISEL verifi-
cation of apoptosis. The levels of tubular epithelial apop-
tosis were significantly greater than controls at 2, 4, and
7 days’ UUO, peaking at 7 days’ UUO (Fig. 6D) [2 and
4 days’ UUO (P < 0.05) and 7 days’ UUO (P < 0.001,
compared with controls)]. Interstitial apoptosis occurred
at moderate levels and was significantly greater than con-
trols at 2 and 4 days’ UUO (P < 0.05). The increased
levels of apoptosis in the interstitium may indicate an
attempt by the UUO kidneys to control an increasing
and abnormal interstitial population in the early stages
of fibrosis [37]. The absolute numbers of mitotic versus
apoptotic cells per mm2 of tissue in the tubular epithelium
(Figs. 5D and 6D) indicated increasing apoptosis and de-
creasing mitosis at 7 days. These results explain, in part,
the development of tubular atrophy that is integral to the
pathogenesis of tubulointerstitial fibrosis after UUO.
ERK activation and localization after UUO
In an in vitro model of renal fibrosis induced by ox-
idative stress, pERK played a part in sustaining survival
of renal tubular epithelial cells versus cell death of renal
fibroblasts [19]. In the present investigation, expression
of pERK was analyzed during development of UUO-
induced renal fibrosis and pERK localization was com-
pared with localization and levels of cell proliferation,
death, and differentiation in the tubular epithelium ver-
sus interstitium. Western blotting or immunohistochem-
istry verified the presence of pERK, minimally in controls
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Fig. 5. Mitosis in the tubulointerstitium. (A to C) Proliferating cell nuclear antigen (PCNA) immunohistochemistry (IHC) in control, 2 and 7 days’
unilateral ureteral obstruction (UUO) animals, respectively. Examples of PCNA-positive nuclei are demonstrated with arrowheads. (B) A mitotic
cell (morphology) is indicated with an arrow. (C) Apoptotic bodies can be seen in the tubular epithelium (arrows) as well as PCNA-positive nuclei
(arrowheads). (D) The mitotic counts per mm2 of tissue using morphology. (E) Counts of PCNA-positive nuclei. In each case, there were significant
increases in epithelial and interstitial cell proliferation at 2 to 7 days’ UUO. ∗∗P < 0.01; ∗P < 0.05 in comparison with controls.
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Fig. 6. Apoptosis in the tubulointerstitium.
(A and B) Examples of hematoxylin and
eosin–stained control (A) (no apoptosis) and
7 days’ unilateral ureteral obstruction (UUO)
kidney sections (B) (apoptosis in epithelium
indicated with arrows and apoptosis in the
interstitium indicated with arrowhead and
letter “a; ” mitosis in the interstitium indi-
cated with arrowhead and letter “m”). (C) In
situ end labeling (ISEL) verification of pres-
ence of apoptosis (examples of positive nu-
clei arrowed). Tubulointerstitial apoptosis in-
creased from 2 days’ UUO and peaked in the
tubular epithelium at 7 days (D). ∗P < 0.05;
∗∗P < 0.001 compared with controls.
and increasing in UUO animals. Figure 7 shows a repre-
sentative Western blot for pERK and ERK (total endoge-
nous ERK) as well as the mean densitometry. There was
a significant increase in pERK/ERK at 1 to 7 days UUO
(P < 0.05). Localization of pERK was mainly in the col-
lecting ducts of the inner medulla in controls (Fig. 8A),
as part of a double stain with PCNA) and 6 hours’ UUO
animals. However, at later stages of UUO, pERK was
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Fig. 7. Extracellular signal-regulated kinase (ERK) expression and ac-
tivation. Western blot and densitometric analysis for phosphorylated
ERK (pERK) and ERK (endogenous total ERK) are demonstrated.
There was a significant increase in the levels of pERK/ERK at 24 hours
to 7 days’ unilateral ureteral obstruction (UUO) in comparison with
controls. ∗P < 0.05; ∗∗P < 0.01.
seen in the outer medulla and cortex and was prevalent
in tubular epithelial cells (Fig. 8B) (2 days’ UUO), a result
similar to that found by Masaki et al [38].
ERK activation and proliferation
Double labeling of pERK and PCNA in controls and
7 days’ UUO animals is shown in Figure 8A and B.
Figure 8C and D demonstrate the linear regression anal-
ysis of double-stained PCNA and pERK (pERK/PCNA)
against pERK alone. The high R2 values indicate a pos-
itive correlation (P < 0.001) between pERK expressing
cells and PCNA, which strengthened with increasing du-
ration of UUO (Fig. 8D), correlation coefficient.
ERK activation, apoptosis, and differentiation
Interstitial apoptotic cells had dual staining for pERK
and Apoptag, however, the apoptotic cells in the tubular
epithelium were rarely positive for pERK (Fig. 9A and
B). Thus, there is some indication that pERK acts in the
death pathway of interstitial cells, probably fibroblasts
(see Fig. 2), but not the tubular epithelium. There were
no dual-labeled cells for pERK and a-SMA in the intersti-
tium or the tubular epithelium (Fig. 9C). Thus, pERK did
not appear to act directly in the differentiation pathway of
myofibroblasts. There were many pERK-positive epithe-
lial cells adjacent to a-SMA–positive interstitial cells, in-
dicating that there may be paracrine stimulation of these
populations of cells. Figure 9D demonstrates pERK stain-
ing in human UUO tissue. There was spatial agreement
of pERK localization between human and experimental
samples, that is, there was labeling of the tubular epithe-
lium but, rarely, interstitial cells.
Antioxidant modulation of fibrosis
Figure 10 demonstrates Western blot and densitome-
try for pERK, ERK, a-SMA, HO-1, and fibronectin, and
also the 8-OHdG immunohistochemistry index, for con-
trol, 2 and 7 days’ UUO animals, with and without antiox-
idant treatments (vitamin E, NAC, and fluvastatin). The
controls for each antioxidant produced no changes sig-
nificantly different from untreated controls and are not
demonstrated. There was a significant increase in ERK
activation in 2 days’ UUO and UUO plus fluvastatin ani-
mals compared with controls (P < 0.05). ERK activation
with fluvastatin was higher than the UUO levels (P =
0.1243). UUO alone and all UUO plus antioxidant treat-
ments were associated with increased ERK activation at
7 days (P < 0.05), with NAC and fluvastatin associated
with a significant decrease in pERK compared with UUO
alone (P < 0.05). a-SMA was significantly increased in all
UUO animals over controls (P < 0.05). Fluvastatin sig-
nificantly decreased a-SMA compared with UUO alone
at 2 days (P < 0.05). This was verified by immunohisto-
chemistry (Fig. 11A and B controls) (Fig. 11C and D UUO
alone) (Fig. 11E and F UUO plus fluvastatin). HO-1 ex-
pression was significantly increased in all UUO animals
compared with controls. Although HO-1 expression did
not decrease significantly at either 2 or 7 days with UUO
cotreatments, the decrease neared significance at 7 days
with fluvastatin (P = 0.0821). The 8-OHdG IHC index
was significantly reduced at both 2 and 7 days with flu-
vastatin cotreatment compared with UUO alone (P <
0.05), verifying an antioxidant action. Both NAC and flu-
vastatin cotreatment significantly decreased fibronectin
expression at 2 days and fluvastatin decreased fibronectin
expression at 7 days (P < 0.05). Counts for apoptosis and
mitosis are available in Figure 12. Results from controls
and UUO alone are compared with the cotreatments plus
UUO. Only fluvastatin induced a significant change from
UUO alone, that being a reduction in tubular epithelial
apoptosis at 7 days (P < 0.05).
DISCUSSION
Tubulointerstitial fibrosis is a common occurrence
in many renal diseases, including ureteral obstruction
by calculi or tumors, ischemia/reperfusion, and toxic
nephropathies. It is often progressive and can be debili-
tating, leading to end-stage renal disease (ESRD). UUO
is a well-established model of experimental renal injury
that results in fibrosis of the tubulointerstitium via char-
acteristic changes seen in human disease, such as expan-
sion of the renal interstitium via excessive matrix proteins
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Fig. 8. Proliferating cell nuclear antigen
(PCNA) and phosphorylated extracellular
signal-regulated kinase (pERK) localization
(double staining). (A) pERK/PCNA im-
munolocalization in control sections, where
pERK was seen mainly in collecting ducts of
the renal papilla and there were few double-
labeled cells. (B) Localization in 2 days’
unilateral ureteral obstruction (UUO) kid-
neys, where pERK was found in the tubu-
lar epithelium in the outer medulla and
there were many dual-labeled epithelial cells.
(C) The linear regression analysis for dual
labeled pERK/PCNA cells against pERK-
labeled cells. There was a significant corre-
lation between the parameters (P < 0.001),
with the correlation coefficient increasing
with time (D).
Fig. 9. Phosphorylated extracellular signal-regulated kinase (pERK) expression, apoptosis, and cell differentiation (double staining). (A and B)
Dual labeling for apoptosis (brown nuclei) and pERK immunolocalization (red fluorescence) in 2 days’ unilateral ureteral obstructed (UUO)
kidneys. Apoptotic cells in the tubular epithelium (arrow with no asterisk) and the tubular lumen (arrowhead) did not have pERK coexpression.
Interstitial apoptotic cells (arrows with asterisk) also expressed pERK. (C) Immunolocalization for pERK (green in tubular epithelium; arrow)
and a-smooth muscle actin (a-SMA) (red in interstitial myofibroblasts; examples with arrowhead) is demonstrated in a 7 days’ UUO kidney. There
were no cells that stained positive for both proteins. (D) Human UUO tissue immunostained with pERK also demonstrated localization of the
protein in the tubular epithelium (arrows), and not the interstitium.
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Fig. 10. Representative Western immunoblot and mean ± SEM of
densitometry. Controls and 2 and 7 days’ unilateral ureteral obstruc-
tion (UUO) animals with and without the antioxidants vitamin E (vit E),
N-acetylcysteine (NAC), and fluvastatin (fluv), for extracellular signal-
regulated kinase (ERK), phosphorylated ERK (pERK), a-smooth mus-
cle actin (a-SMA), heme oxygenase-1 (HO-1), and fibronectin. The
immunohistochemistry (IHC) index for 8-hydroxy-2′-deoxyguanosine
(8-OHdG) is also demonstrated. ∗P < 0.05 compared with controls;
#P < 0.05 compared with UUO alone.
Fig. 11. Immunolocalization of a-smooth muscle actin (aSMA) is pre-
sented for controls and 2 days’ unilateral ureteral obstruction (UUO)
animals with and without fluvastatin. (A, C, and E) The cortex. (B, D,
and F) The medulla. (A and B) Untreated controls. (C and D) UUO. (E
and F) UUO plus fluvastatin. Expression of a-SMA in the fluvastatin-
treated UUO animals is similar to baseline levels in untreated controls.
production, fibroblast activation or proliferation, mono-
cyte and macrophage infiltration, and tubular atrophy.
These changes may be mediated, in part, by intracellu-
lar pathways that are initiated by oxidative stress [18, 19,
39]. The present study verified the development of tubu-
lointerstitial fibrosis by describing significant increases in
ECM proteins and a-SMA–positive interstitial cells with
increasing duration of UUO.
Oxidative stress plays a role in promoting renal fi-
brosis in some instances. Moriyama et al [12] recently
demonstrated increased oxidative stress in the intersti-
tium of UUO kidneys based on the increased expression
of HO-1 mRNA and immunohistochemistry detection
of advanced glycation end products (AGE) in the in-
terstitium. AGE products can promote transdifferenti-
ation of renal epithelial cells to a myofibroblast a-SMA–
expressing phenotype [40]. Fluvastatin, a 3-hydroxy-
3-methylglutaryl coenzyme A (HMG-CoA) reductase
inhibitor, was used by Moriyama et al as antioxidant ther-
apy in the UUO animals’ diet and it caused a slight but
significant attenuation of tubulointerstitial fibrosis, indi-
cating a causal relationship between oxidative stress and
renal fibrosis. Oxidative stress is difficult to measure di-
rectly in vivo, and the alternative of monitoring stress-
inducible genes like HO-1 has found acceptance. HO-1 is
the rate-limiting enzyme that catalyses heme degradation
to bilverdin and ultimately to bilirubin, liberating carbon
monoxide and free iron in the process [41]. Its induction
occurs in cells and tissues after renal ischemia/reperfusion
injury [42], hypertension [32], UUO [11, 12], and expo-
sure to urea [43]. In addition, 8-OHdG is seen as a ro-
bust measure of oxidant-induced DNA damage [27]. The
results of the present study verified an involvement of
oxidative stress in UUO-induced fibrosis.
In progressive obstructive nephropathy, the renal
tubules dilate and tubular epithelial cells undergo apop-
tosis, leading to tubular atrophy. There is also a high
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Fig. 12. The mean ± SEM of mitosis and apoptosis in the tubu-
lar epithelium is demonstrated for untreated controls, unilateral
ureteral obstruction (UUO) and UUO plus antioxidants [vitamin E,
N-acetylcysteine (NAC) and fluvastatin] at 2 and 7 days. In a compari-
son of UUO alone with UUO plus antioxidants, only fluvastatin (fluv)
was associated with a significant decrease in tubular epithelial apopto-
sis. ∗P < 0.05 compared with controls; #P < 0.05 compared with UUO
alone.
level of cell proliferation in the tubular epithelium in the
early stages of fibrogenesis [6–8]. The present study con-
firmed these results and also established that moderate
but significant interstitial cell proliferation and apoptosis
occurred, demonstrating the dynamic nature of the inter-
stitium during the development of fibrosis. The involve-
ment of signal transduction pathways in this dynamic pro-
cess of epithelial and interstitial cell proliferation and
death has received little attention to date. The MAPK
pathways are well characterized in other instances of cell
proliferation and death [20, 44]. We had some indication,
in renal fibrosis, that the pERK pathway had cell spe-
cific roles, promoting growth or protection of the renal
tubular epithelium but cell death of renal fibroblasts af-
ter oxidative stress [19]. The present investigation sought
to determine if this same association occurred in the in
vivo UUO model of renal fibrosis, known to have similar
causative features.
Western blot analysis indicated that pERK/ERK in-
creased significantly at 1 to 7 days’ UUO in compari-
son with controls, a result similar to that seen in renal
tubular epithelial and fibroblast cells in vitro after oxida-
tive stress. The positive relationship between pERK and
promotion of epithelial cell growth and survival, seen in
vitro after oxidative stress, was matched by the positive
correlation between pERK and tubular epithelial pro-
liferation (PCNA labeling) seen in vivo. Similar results
have been published recently by others [38]. Dual label-
ing of pERK and apoptosis indicated that pERK did not
act in the death pathway of tubular epithelial cells but
there was some dual labeling of interstitial cells. pERK
did not localize with a-SMA–expressing fibroblasts, in-
dicating it does not act in their differentiation pathway
in this in vivo model. A close spatial relationship be-
tween many pERK-positive epithelial cells and adjacent
a-SMA–positive interstitial cells was seen, indicating that
there may be paracrine stimulation of myofibroblasts, for
example, by growth factors synthesized in the epithe-
lium under the protective influence of pERK. A similar
characteristic has been recorded previously where cor-
tical fibroblasts benefited from paracrine stimulation by
proximal tubular epithelial cells grown in vitro in close
proximity to the fibroblasts [45].
There were few inconsistencies between the original
in vitro model and this in vivo study, and these related
mainly to the moderate levels of apoptosis seen in vivo
versus the high levels that were able to be induced by ox-
idative stress in the in vitro model of renal fibrosis. A com-
parison of pERK expression and fibrosis from the models
is summarized in Table 1. Differences between in vitro
and in vivo results are not surprising, and similar dispar-
ities have been published elsewhere [46]. In the in vitro
investigation that was used as a model for the present
study [19], a single cause of fibrosis (oxidative stress)
was analyzed against pERK activation in very specific
renal cell populations (renal tubular epithelium, fibrob-
lasts, and endothelium). The outcome mimicked some
of the characteristics seen in renal fibrosis. We had been
able to verify the cell-specific roles for pERK, in vitro, us-
ing the specific inhibitor (PD98059) of MEK (MAPK or
ERK kinases), a precursor of ERK [19]. Undoubtedly, in
vivo, the model is much more complex and the causes of
fibrosis multifactorial. The ERK pathway is traditionally
considered to act in cell proliferation and, sometimes,
differentiation rather than cell death. The in vitro and
now the in vivo UUO model also indicate a link between
pERK and fibroblast or interstitial cell death.
The results of the present analysis of modulation of
oxidative stress by antioxidants in UUO-induced fibrosis
supported the work of Moriyama et al (2002) who re-
ported an attenuation of tubulointerstitial fibrosis with
fluvastatin treatment via an antioxidant mechanism. We
have now demonstrated that this mechanism appears
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Table 1. Summary of the spatiotemporal association between extracellular signal-regulated kinase (ERK) activation and fibrotic changes in the
current in vivo model and the in vitro model [19] on which this study was based
ERK activation in oxidant-associated fibrotic injury
Early Late
In vitro [19] Prevents early decrease in tubular epithelial survival ↑ ERK activity does not appear to affect long-term survival of
tubular epithelial cells
↑ ERK activity parallels increases in fibroblast apoptosis Promotes fibroblast apoptosis
In vivo Association with tubular epithelial proliferation ↑ ERK activity does not affect survival or apoptosis
↑ ERK activity may ↓ myofibroblast activation and fibronectin
production via an antioxidant mechanism
↓ ERK activity may inhibit apoptosis and fibronectin
production via an antioxidant mechanism
Associated expression of pERK in apoptotic interstitial cells
(possibly myofibroblasts) but not in viable cells
also to involve time-dependent changes in pERK, which
may reduce the infiltration of myofibroblasts or excessive
tubular apoptosis. Of the other antioxidants used in the
present study, only NAC induced a significant decrease
in fibronectin expression and tubular epithelial apopto-
sis. The present study also demonstrated, however, that
there was a significant fluvastatin and NAC treatment-
associated decrease in pERK compared with UUO alone
at 7 days. In studies with rabbits, a reduction in cardiac
fibrosis and hypertrophy with simvastatin treatment, a
drug in the same statin class as fluvastatin, was also asso-
ciated with a significant reduction in ERK activation [44].
The exact biologic outcome of the altered ERK activity
still needs elucidation.
CONCLUSION
The present study has demonstrated a role for the acti-
vated ERK protein in renal fibrogenesis under the influ-
ence of oxidative stress. Expression of pERK in tubular
epithelial cells was associated spatially and temporally
with their proliferation. Interstitial fibroblasts expressed
no pERK, except where they were apoptotic. Thus, the
biologic outcome of altered pERK expression appears
to be cell type–specific. Fluvastatin acted as an antioxi-
dant and was the best of the three treatments analyzed in
attenuating fibrosis. Fluvastatin also was associated with
altered pERK, which continues to be an attractive antifi-
brotic signaling target. The antifibrotic benefit of modu-
lation of one specific signal transduction pathway (Rho)
has already been demonstrated by Nagatoya et al [47]
in renal fibrosis. Thus, in a similar fashion, the value of
modulated expression of pERK in promoting survival or
proliferation of tubular epithelial cells but the death of
fibroblasts needs further analysis.
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